Related Experiment Videos
Theiler's virus infection of beta 2-microglobulin-deficient mice
1Unité des Virus Lents, UA 1157 Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France.
Abstract:
Theiler's virus, a murine picornavirus, persists in the central nervous systems of susceptible mice and induces a chronic demyelinating disease. Susceptibility or resistance to this disease is controlled in part by the H2-D locus of the major histocompatibility complex (MHC). For this reason, it has been proposed that CD8+ class I-restricted cytotoxic T cells play a main role in the pathogenesis of this viral infection. We recently reported the existence of anti-virus CD8+ cytotoxic T cells in the course of Theiler's virus infection. In the present study, we examined the role of these effector cells in mice in which the beta 2-microglobulin gene had been disrupted. These mice fail to express class I MHC molecules and therefore lack CD8+ T cells. The mice are derived from a C57BL/6 x 129/Ola cross and are H-2b, a haplotype associated with resistance to Theiler's virus infection. beta 2-Microglobulin-deficient mice (beta 2m-/-mice) failed to clear the virus, developed demyelination, and, interestingly, did not succumb to early infection. These results demonstrate that CD8+ T cells are required to clear Theiler's virus infection. In contrast with a current hypothesis, they also demonstrate that CD8+ T cells are not major mediators of the demyelinating disease.
Insights
CD8+ T cells are essential for clearing Theiler
Area of Science:
- Neuroimmunology
- Virology
- Immunology
Background:
- Theiler's virus causes chronic demyelinating disease in mice.
- Major histocompatibility complex (MHC) class I and CD8+ T cells are implicated in disease pathogenesis.
- Previous studies suggested CD8+ T cells mediate demyelination.
Purpose of the Study:
- To investigate the role of CD8+ T cells in Theiler's virus infection and demyelination.
- To determine if CD8+ T cells are required for viral clearance or disease mediation.
Main Methods:
- Utilized beta 2-microglobulin-deficient (beta 2m-/-) mice lacking MHC class I molecules and CD8+ T cells.
- Infected beta 2m-/- mice and compared outcomes to wild-type mice.
- Assessed viral clearance, demyelination, and disease progression.
Main Results:
- Beta 2m-/- mice failed to clear Theiler's virus.
- Demyelination occurred in beta 2m-/- mice, but they were protected from early mortality.
- These findings indicate CD8+ T cells are crucial for viral clearance.
Conclusions:
- CD8+ T cells are required for clearing Theiler's virus infection.
- Contrary to prevailing hypotheses, CD8+ T cells are not the primary drivers of demyelinating disease in this model.